Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary Dysplasia
Open Access
- 20 May 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 3, 21
Abstract
In contrast to many other organs, a significant portion of lung development occurs after birth during alveolarization, thus rendering the lung highly susceptible to injuries that may disrupt this developmental process. Premature birth heightens this susceptibility, with many premature infants developing the chronic lung disease, bronchopulmonary dysplasia (BPD), a disease characterized by arrested alveolarization. Over the past decade, tremendous progress has been made in the elucidation of mechanisms that promote postnatal lung development, including extensive data suggesting that impaired pulmonary angiogenesis contributes to the pathogenesis of BPD. Moreover, in addition to impaired vascular growth, patients with BPD also frequently demonstrate alterations in pulmonary vascular remodeling and tone, increasing the risk for persistent hypoxemia and the development of pulmonary hypertension. In this review, an overview of normal lung development will be presented, and the pathologic features of arrested development observed in BPD will be described, with a specific emphasis on the pulmonary vascular abnormalities. Key pathways that promote normal pulmonary vascular development will be reviewed, and the experimental and clinical evidence demonstrating alterations of these essential pathways in BPD summarized.Keywords
Funding Information
- National Institutes of Health (R01 HL122918)
- Stanford Child Health Research Institute
- Stanford CHRI Transdisciplinary Initiative Program
This publication has 144 references indexed in Scilit:
- Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarizationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheepAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- LPA Receptors: Subtypes and Biological ActionsAnnual Review of Pharmacology and Toxicology, 2010
- Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodelingAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993